A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) became a global human health threat since its first documentation in humans in 2012. An efficient vaccine for the prophylaxis of humans in hotspots of the infection (e.g., Saudi Arabia) is necessary but no commercial vaccines are yet approved....

Descripción completa

Detalles Bibliográficos
Autores principales: Shehata, Mahmoud M., Kandeil, Ahmed, Mostafa, Ahmed, Mahmoud, Sara H., Gomaa, Mokhtar R., El-Shesheny, Rabeh, Webby, Richard, Kayali, Ghazi, A. Ali, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963271/
https://www.ncbi.nlm.nih.gov/pubmed/31810359
http://dx.doi.org/10.3390/pathogens8040281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963271/
https://www.ncbi.nlm.nih.gov/pubmed/31810359
http://dx.doi.org/10.3390/pathogens8040281

Ejemplares similares